Moreover, studies in animal models of multiple sclerosis have shown the TNF‐STAT1‐CXCL10 axis to contribute to pathology, and it has been suggested as a promising therapeutic target (Rahmat‐Zaie et al. 2023). The gene discussed is STAT1; the disease is multiple sclerosis.